Home » Topics » Regulatory

Regulatory
RSS

Aceon sNDA accepted for filing with priority review

Feb. 18, 2005

Arixtra receives new approval in Europe

Feb. 10, 2005

Fendrix hepatitis B vaccine approved in Europe

Feb. 9, 2005

Positive opinion for new Thyrogen indication in Europe

Jan. 27, 2005

Taxotere approved for two new indications in Europe

Jan. 13, 2005

Abraxane approved for metastatic breast cancer

Jan. 11, 2005

Prialt receives FDA approval for severe chronic pain

Dec. 30, 2004

Clolar approved for pediatric ALL

Dec. 30, 2004

Finasteride tested to treat alcoholism

Dec. 30, 2004

Vfend approved for candidemia in nonneutropenic patients

Dec. 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...